BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Sabre//Sabre VObject 4.6.1//EN
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Europe/Zurich
X-LIC-LOCATION:Europe/Zurich
TZURL:http://tzurl.org/zoneinfo/Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:19810329T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:19961027T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:news10@biomedizin.unibas.ch
DTSTAMP;TZID=Europe/Zurich:20170927T113406
DTSTART;TZID=Europe/Zurich:20171003T123000
SUMMARY:Basel Breast Consortium Tricycle Lunchtime Seminar
DESCRIPTION:Thomas Reinheckel\, University of Freiburg"Lysosomal proteases 
 in breast cancer - is there a link to targeted therapies?"Frank Zimmermann
 \, University Hospital Basel"Personalized radiation therapy in breast canc
 er - adaptive techniques and individualized decision making"Dirk Weber\, C
 ellestia Biotech AG\, Basel"Aberrant NOTCH Signalling in Breast Cancer: an
  attractive target for pan-NOTCH inhibition"
X-ALT-DESC:Thomas Reinheckel\, University of Freiburg<br />&quot\;Lysosomal
  proteases in breast <br />cancer - is there a link to targeted <br />ther
 apies?&quot\;<br />Frank Zimmermann\, University Hospital Basel<br />&quot
 \;Personalized radiation therapy in breast cancer - adaptive techniques an
 d individualized decision making&quot\;<br />Dirk Weber\, Cellestia Biotec
 h AG\, Basel<br />&quot\;Aberrant NOTCH Signalling in Breast <br />Cancer:
  an attractive target for pan-NOTCH inhibition&quot\; 
DTEND;TZID=Europe/Zurich:20171003T133000
END:VEVENT
END:VCALENDAR